Embark Veterinary vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 74)
Embark Veterinary logo

Embark Veterinary

LeaderHealthcare

Animal Health & Veterinary Genomics

Embark Veterinary is the leading dog DNA testing company, screening 270+ health conditions across 400+ breeds with 99% breed accuracy; partnered with Cornell Veterinary College and serving 700+ shelters.

AI VisibilityBeta
Overall Score
B74
Category Rank
#85 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
74
Gemini
76

About

Embark Veterinary is a canine genomics company based in Boston, Massachusetts, offering the most comprehensive dog DNA tests available to pet owners, breeders, and veterinarians. Founded in 2015 by brothers Adam Boyko and Ryan Boyko — with scientific advisory from Cornell University''s College of Veterinary Medicine — Embark screens for more than 270 genetic health conditions and identifies more than 400 breeds, types, and varieties with 99% breed identification accuracy. Its tests provide pet owners with actionable health insights, ancestry breakdowns, trait analysis, and connections to canine relatives.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

74
Overall Score
86
#85
Category Rank
#12
80
AI Consensus
67
stable
Trend
stable
76
ChatGPT
80
74
Perplexity
81
76
Gemini
92
68
Claude
90
72
Grok
83

Key Details

Category
Animal Health & Veterinary Genomics
Weight Health Platform
Tier
Leader
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.